RFK Jr. Announces FDA Peptide Ban Reversal: What You Need to Know
In a February 27, 2026 appearance on the Joe Rogan Experience podcast, Health and Human Services Secretary Robert F. Kennedy Jr. articulated intentions to pursue reclassification of approximately 14 peptides from FDA Category 2 status back to Category 1, a policy reversal that, if implemented, would restore legal compounding access to compounds prohibited since September

